Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation -STROKESTOP II

医学 心房颤动 随机对照试验 内科学 冲程(发动机) 入射(几何) 心脏病学 儿科 机械工程 物理 光学 工程类
作者
Katrin Kemp Gudmundsdottir,Emma Svennberg,Leif Friberg,Tove Hygrell,Viveka Frykman,Faris Al‐Khalili,Ziad Hijazi,Mårten Rosenqvist,Johan Engdahl
出处
期刊:Circulation [Ovid Technologies (Wolters Kluwer)]
被引量:2
标识
DOI:10.1161/circulationaha.124.071176
摘要

Background: Guidelines have suggested screening for atrial fibrillation to enable early treatment and avoid downstream negative clinical events. We aimed to determine if atrial fibrillation screening potentially enhanced by NT-proBNP would reduce stroke or systemic embolism incidence as compared to in a control group and to determine if it was safe for those with low NT-proBNP concentrations to forfeit prolonged screening. Methods: In this randomized controlled trial all 75/76-year-old individuals in Stockholm Region, Sweden were randomized 1:1 to be invited to screening or serve as a control group. NT-proBNP concentration were measured and a single-lead-ECG registered only once if NT-proBNP<125ng/L, whereas if NT-proBNP≥125 ng/L participants underwent prolonged screening, recording single-lead ECGs four times daily for two weeks. If atrial fibrillation was detected, treatment was initiated. Baseline and outcome data were collected from Swedish National Registries. Results: In total 28,712 individuals were randomized, after exclusion of death and emigration 13,905 remained in the intervention group, 13,884 in the control group. Participation rate in the intervention group was 49.2% (6,843/13,905). Participants in the high NT-proBNP group (NT-proBNP≥125 ng/L) without prior atrial fibrillation constituted 60% of the total and underwent prolonged screening. New AF was detected in 2.4% (165/6,843) in the intervention group. There was no difference in AF prevalence or oral anticoagulant treatment between the intervention and the control group after five years follow-up. After a median of 5.1 years (IQR 5.0-5.8) there was no difference in the primary outcome of stroke or systemic embolism between the intervention group and the control group, HR: 0.96 (95% CI 0.86-1.06). The low NT-proBNP-group had significantly fewer strokes or systemic emboli than the control group, HR: 0.59 (95% CI 0.46-0.74), p<0.001. In the high NT-proBNP group the risk of stroke or systemic embolism was higher compared to the low NT-proBNP group, HR: 1.57 (95% CI 1.22-2.02), p=0.001. Conclusions: In this population-based screening trial for atrial fibrillation using NT-proBNP for screening enhancement, there was no difference in risk of stroke or systemic embolism for the intervention group compared to controls. Participation was moderate. The use of NT-proBNP for screening enhancement was safe in identifying low-risk participants. Clinical Trial Registration: www.clinicaltrials.gov; NCT02743416
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怡然雁凡完成签到,获得积分10
刚刚
顾jiu完成签到,获得积分10
1秒前
科研通AI5应助热依汗古丽采纳,获得10
1秒前
优秀剑愁完成签到 ,获得积分10
1秒前
敏感网络发布了新的文献求助50
2秒前
院士人启动完成签到,获得积分10
2秒前
3秒前
黄花菜完成签到 ,获得积分0
5秒前
5秒前
顾jiu发布了新的文献求助30
5秒前
Yimim完成签到,获得积分10
5秒前
6秒前
白菜完成签到,获得积分10
6秒前
7秒前
虚心山灵完成签到 ,获得积分20
7秒前
8秒前
白菜发布了新的文献求助30
9秒前
9秒前
xx发布了新的文献求助10
10秒前
Vii应助追寻的白安采纳,获得10
10秒前
科研通AI5应助Laus采纳,获得10
10秒前
小周发布了新的文献求助10
10秒前
万能图书馆应助自信鞯采纳,获得10
10秒前
SherlockLiu发布了新的文献求助30
11秒前
姚博士快毕业完成签到,获得积分10
12秒前
无语大王完成签到,获得积分10
12秒前
怡然的莫茗完成签到,获得积分10
13秒前
清秀的以云完成签到,获得积分20
14秒前
猫好好完成签到,获得积分10
15秒前
16秒前
hhzz完成签到,获得积分10
16秒前
16秒前
xhemers完成签到,获得积分10
16秒前
111发布了新的文献求助10
16秒前
17秒前
爱静静应助怡然的莫茗采纳,获得10
18秒前
19秒前
科研通AI5应助清秀的以云采纳,获得30
19秒前
李健的粉丝团团长应助xx采纳,获得10
21秒前
大豪子发布了新的文献求助30
21秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808